IN8BIO, INC. — Director's Dealing 2021

Jul 30, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-07-29

Reporting Person: Roemer Alan S. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	29674	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$6.7398	2030-10-04	Common Stock (225879)		Direct

Footnotes

F1: The shares subject to the option shall vest in twelve (12) equal quarterly installments commencing December 9, 2020, subject to the Reporting Person
continuing to provide service through each such date.